search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    Aldeyra Therapeutics, Inc.

    (NASDAQ:ALDX)

    $4.03

    $0.23

    6.05%

    Aldeyra Therapeutics, Inc. Chart

    ALDX Stock Price Today

    Aldeyra Therapeutics, Inc. (ALDX) stock rallied over 6.05% intraday to trade at $4.03 a share on NASDAQ. The stock opened with a gain of 1.51% at $3.73 and touched an intraday high of $4.055, rising 6.05% against the last close of $3.8. The stock went to a low of $3.72 during the session.

    Stock Snapshot

    $3.8

    Prev. Close

    246.68 Million

    Market Cap

    $3.72

    Day Low

    $3.73

    Open

    58.3 Million

    Number of Shares

    $4.055

    Day High

    -

    P/E ratio

    -1.11

    EPS (TTM)

    1.80

    Cash Flow per Share

    8.46

    Free Float in %

    3.78

    Book Value

    546,043

    Volume

    Aldeyra Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-05$3.73$4.055$3.72$4.03541,382
    2022-07-01$3.97$4.07$3.75$3.8579,700
    2022-06-30$3.81$4.04$3.81$3.99570,500
    2022-06-29$3.96$4.01$3.81$3.93655,600
    2022-06-28$3.95$4.04$3.87$3.99792,200
    2022-06-27$3.78$3.93$3.58$3.871,047,300
    2022-06-24$3.62$3.74$3.43$3.686,580,600
    2022-06-23$3.17$3.64$3.17$3.591,220,800
    2022-06-22$3.14$3.355$3.08$3.171,227,900
    2022-06-21$3.44$3.45$3.16$3.181,419,000

    Contact Details

    131 Hartwell Avenue
    Suite 320
    Lexington, MA 02421
    United States

    Webiste:ALDX

    781 761 4904

    Company Information

    Employees-

    Beta1.36

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of primary vitreoretinal lymphoma. The company's portfolio also consists of ADX-1612, a small molecule heat shock protein 90 (Hsp90) inhibitor for the treatment of lymphoproliferative diseases and covid-19; and reactive aldehyde species that are pro-inflammatory (RASP) scavengers, such as ADX-629 for treating autoimmune diseases, allergy, and covid-19, as well as ADX-103 for the treatment of retinal diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is headquartered in Lexington, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Aldeyra Therapeutics, Inc. (ALDX) stock price?

    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) stock price is $4.03 as of the last check on Tuesday, July 5. During the trading session, ALDX stock reached the peak price of $4.055 while $3.72 was the lowest point it dropped to.

    icon

    ALDX's industry and sector of operation?

    The NASDAQ listed ALDX is part of Biotechnology industry that operates in the broader Health Care sector. Aldeyra Therapeutics, Inc. , a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases.

    icon

    Who are the executives of ALDX?

    Dr. Todd C. Brady M.D., Ph.D.
    CEO, Pres & Director
    Mr. Joshua Reed M.B.A.
    Chief Financial Officer
    Dr. Stephen G. Machatha Ph.D.
    Chief Devel. Officer
    Mr. Kelly Mizer
    VP of Commercial Strategy & Operations

    icon

    What is the ALDX stock price today?

    ALDX stock traded closed the last session at $4.03, which is $0.23 or 6.05% lower than its previous close of $3.8. ALDX's current trading price is 71.13% lower than its 52-week high of $11.33 where as its distance from 52-week low of 2.36% is -64.43%.

    icon

    How many employees does ALDX have?

    Number of ALDX employees currently stands at -. ALDX operates from 131 Hartwell Avenue, Suite 320, Lexington, MA 02421, United States.

    icon

    Link for ALDX official website?

    Official Webiste of $ALDX is: https://www.aldeyra.com

    icon

    How do I contact ALDX?

    ALDX could be contacted at ALDX operates from 131 Hartwell Avenue, Suite 320, Lexington, MA 02421, United States, or at phone #781 761 4904 and can also be accessed through its website.

    icon

    How many shares of ALDX are traded daily?

    ALDX stock volume for the day was 546,043 shares while in the previous session number of ALDX shares traded was 541,382 . The average number of ALDX shares traded daily for last 3 months was 941.44 Thousands.

    icon

    How much did ALDX change today?

    The percentage change in ALDX stock occurred in the recent session was 6.05% while the dollar amount for the price change in ALDX stock was $0.23.

    icon

    What price range ALDX stock been trading in?

    In the recent session, the day high for ALDX stock was $4.055 while the low for ALDX stock touched on the day was $3.72.

    icon

    What is the market cap of ALDX currently?

    The market value of ALDX currently stands at 246.68 Million with its latest stock price at $4.03 and 58.3 Million of its shares outstanding.